Gregory P. Levin

613 total citations
7 papers, 425 citations indexed

About

Gregory P. Levin is a scholar working on Pathology and Forensic Medicine, Nephrology and Management Science and Operations Research. According to data from OpenAlex, Gregory P. Levin has authored 7 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 2 papers in Nephrology and 2 papers in Management Science and Operations Research. Recurrent topics in Gregory P. Levin's work include Vitamin D Research Studies (4 papers), Statistical Methods in Clinical Trials (2 papers) and Parathyroid Disorders and Treatments (2 papers). Gregory P. Levin is often cited by papers focused on Vitamin D Research Studies (4 papers), Statistical Methods in Clinical Trials (2 papers) and Parathyroid Disorders and Treatments (2 papers). Gregory P. Levin collaborates with scholars based in United States, Sweden and United Kingdom. Gregory P. Levin's co-authors include Cassianne Robinson‐Cohen, Ian H. de Boer, Bryan Kestenbaum, Andrew N. Hoofnagle, David S. Siscovick, Jonathan Himmelfarb, John Ruzinski, Stephen M. Schwartz, Bessie A. Young and Michael C. Sachs and has published in prestigious journals such as JAMA, American Journal of Clinical Nutrition and Biometrics.

In The Last Decade

Gregory P. Levin

7 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory P. Levin United States 6 332 113 93 61 54 7 425
Pan Wei United States 3 278 0.8× 142 1.3× 37 0.4× 71 1.2× 31 0.6× 4 387
Julia B. Zella United States 8 294 0.9× 107 0.9× 38 0.4× 45 0.7× 80 1.5× 11 461
Mario Taranto Australia 9 268 0.8× 127 1.1× 96 1.0× 34 0.6× 40 0.7× 10 364
Nejla Latic Austria 7 180 0.5× 80 0.7× 31 0.3× 53 0.9× 20 0.4× 11 309
Sylvana Prokop Germany 11 315 0.9× 137 1.2× 89 1.0× 14 0.2× 54 1.0× 15 408
Chih‐Chien Sung Taiwan 8 184 0.6× 75 0.7× 24 0.3× 21 0.3× 38 0.7× 24 395
Adriaan van Sorge Netherlands 8 141 0.4× 54 0.5× 37 0.4× 97 1.6× 16 0.3× 9 346
Bakr Swaid United States 5 197 0.6× 100 0.9× 69 0.7× 15 0.2× 14 0.3× 9 301
Indira Maisnam India 10 156 0.5× 53 0.5× 46 0.5× 24 0.4× 16 0.3× 25 395

Countries citing papers authored by Gregory P. Levin

Since Specialization
Citations

This map shows the geographic impact of Gregory P. Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory P. Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory P. Levin more than expected).

Fields of papers citing papers by Gregory P. Levin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory P. Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory P. Levin. The network helps show where Gregory P. Levin may publish in the future.

Co-authorship network of co-authors of Gregory P. Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory P. Levin. A scholar is included among the top collaborators of Gregory P. Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory P. Levin. Gregory P. Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Levin, Gregory P., Sarah C. Emerson, & Scott S. Emerson. (2014). An evaluation of inferential procedures for adaptive clinical trial designs with pre‐specified rules for modifying the sample size. Biometrics. 70(3). 556–567. 7 indexed citations
2.
Sachs, Michael C., Abigail B. Shoben, Gregory P. Levin, et al.. (2013). Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis. American Journal of Clinical Nutrition. 97(6). 1243–1251. 114 indexed citations
3.
Levin, Gregory P., Cassianne Robinson‐Cohen, Ian H. de Boer, et al.. (2012). Genetic Variants and Associations of 25-Hydroxyvitamin D Concentrations With Major Clinical Outcomes. JAMA. 308(18). 1898–1898. 147 indexed citations
4.
Shoben, Abigail B., Gregory P. Levin, Ian H. de Boer, et al.. (2012). Variation in Oral Calcitriol Response in Patients With Stages 3-4 CKD. American Journal of Kidney Diseases. 59(5). 645–652. 1 indexed citations
5.
Levin, Gregory P., Cassianne Robinson‐Cohen, Andrew N. Hoofnagle, et al.. (2012). The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease. Kidney International. 82(6). 693–700. 121 indexed citations
6.
Levin, Gregory P., Sarah C. Emerson, & Scott S. Emerson. (2012). Adaptive clinical trial designs with pre‐specified rules for modifying the sample size: understanding efficient types of adaptation. Statistics in Medicine. 32(8). 1259–1275. 17 indexed citations
7.
Levin, Gregory P., et al.. (1988). Incidence of otosclerosis.. PubMed. 9(4). 299–301. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026